A cannabis research and development deal hailed just last March as a $300 million partnership has morphed into a nearly $1 billion court battle. New York-based Lavvan filed an $881 million suit against its partner, California-headquartered Amyris, alleging misappropriation of trade secrets and patent infringement. According to a news release, Lavvan specifically accused the company […]
Synthetic cannabinoid partnership devolves into $881 million lawsuit is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Be First to Comment